sharecast

{{ storiesRelated.title }}

Market Live Email
21 Dec
dl astrazeneca ftse 100 astra zeneca health care healthcare pharmaceuticals and biotechnology pharmaceuticals logo
AstraZeneca announces two drug approvals in the EU

AstraZeneca announced two EU approvals on Wednesday, with Imfinzi approved for biliary tract cancer, and Lynparza for prostate cancer.